Eliminating the Category II Retreatment Regimen from National Tuberculosis Programme Guidelines: The Georgian experience/Suppression Du Schema De Retraitement De Categorie II Des Directives Therapeutiques Nationales Du Programme De Lutte Contre la Tuberculose: L'experience georgienne/Eliminacion De Las Pautas De Repeticion del Tratamiento De Categoria II De Las Directrices del Programa Nacional Contra la Tuberculosis: El Caso De Georgia
Jennifer Furin, Iagor Kalandadze(National Center for Tuberculosis and Lung Disease), Rocio Hurtado(Harvard University), Jacob Joseph(Lourdes Hospital), Carole D. Mitnick(Brigham and Women's Hospital), Michael Rich, Medea Gegia(World Health Organization), Peter Drobac(University of Oxford), Mercedes C. Becerra(Brigham and Women's Hospital), Paul Farmer(Harvard University), Sonya Shin(Brigham and Women's Hospital), Salmaan Keshavjee(Brigham and Women's Hospital)
Bulletin of the World Health Organization
January 1, 2012
Cited by 0
Related Papers
Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis
|Clinical Infectious Diseases|2016|1.5k
Structural Violence and Clinical Medicine
|PLoS Medicine|2006|1.1k
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis
|The Lancet|2018|639